Viewing nowOlmesartan Medoxomil Tablets 20mg
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

MFDS item code 201100905 · Approved 2011.02.24 · Insurance code 649505950
Treatment of essential hypertension
Essential hypertension is a condition where blood pressure is persistently elevated, placing a burden on the cardiovascular system. This medication helps stabilize blood pressure by directly regulating the causes of essential hypertension. By lowering blood pressure to an appropriate level, it effectively reduces the burden on the heart and blood vessels, preventing complications. Consistent use maintains blood pressure control and improves overall cardiovascular health. Therefore, it is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be coadministered with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose while their condition is monitored carefully. <Elderly patients> No dose adjustment is required when this medicine is administered to patients aged 65 years or older. Although no overall differences in efficacy and safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
<Children> The safety and efficacy in children have not been established.
This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be stopped immediately if pregnancy is confirmed. Persons allergic to any of the ingredients in this medication, those who are pregnant or breastfeeding, patients undergoing kidney dialysis, those with severe liver dysfunction, and those with biliary obstruction should not take this medication. Individuals with lactose intolerance should also avoid this medication, and caution is needed for certain diabetic patients or patients with significantly decreased kidney function. Patients with decreased blood volume or low sodium may experience symptoms of hypotension when first taking this medication, so they should be closely monitored. In patients with severe heart failure whose kidney function relies on the renin-angiotensin-aldosterone system, there is a risk of renal function worsening, so caution is advised. Patients with decreased kidney function or those who have undergone kidney transplantation should regularly check kidney status and electrolyte levels through blood tests. Patients with vascular problems in the kidneys or those at risk of hyperkalemia should carefully monitor serum potassium levels when taking this medication. Patients with aortic or mitral valve stenosis or obstructive heart disease should use this medication with special caution. Due to its blood pressure-lowering effects, this medication may cause dizziness, so it's advisable to avoid hazardous activities such as high places or driving. This medication has generally been used safely in clinical trials; however, mild side effects such as dizziness, headache, back pain, indigestion, and cough may occur. Serious side effects such as angioedema, liver dysfunction, hyperkalemia, and acute kidney failure have been reported rarely, so if any abnormal symptoms occur, consult a physician immediately. If gastrointestinal symptoms like chronic diarrhea or weight loss persist, discontinue use and consult a physician. When taken with potassium-sparing diuretics, potassium supplements, or certain anti-inflammatory pain relievers, serum potassium levels can rise dangerously, so caution is needed with concurrent use. Co-administration with lithium preparations may increase lithium concentration and lead to toxicity, so it is advisable not to take them together. Taking this medication with other antihypertensive drugs may enhance the blood pressure-lowering effect, so consult healthcare professionals. Pregnant women should be informed of the serious risks to the fetus, so if planning for pregnancy or already pregnant, ensure to inform healthcare providers. Breastfeeding mothers should consider discontinuing breastfeeding or this medication as it may pass into breast milk. Safety for children has not been established, so it should be administered to children with caution. In elderly patients, there may be increased drug concentration in the body, so dosage adjustments and careful monitoring are necessary. In case of overdose, symptoms such as hypotension, palpitations, and bradycardia may appear, and immediate medical attention should be sought if symptoms are severe.
Dizziness
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is recommended to maintain storage temperature between 1 degree and 25 degrees Celsius at room temperature. This will help preserve the medication's effectiveness for a longer time.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.